{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:18:01Z","timestamp":1789568281321,"version":"build-2803163510"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41584-025-01290-1","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:35:27Z","timestamp":1756226127000},"page":"626-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pain in systemic lupus erythematosus: emerging insights and paradigms"],"prefix":"10.1038","volume":"21","author":[{"given":"David S.","family":"Pisetsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Eudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-3688","authenticated-orcid":false,"given":"Ru-Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-1676","authenticated-orcid":false,"given":"Peter E.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"1290_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2, 16039 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1290_CR2","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6","volume":"42","author":"SG Barr","year":"1999","unstructured":"Barr, S. G., Zonana-Nacach, A., Magder, L. S. & Petri, M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum. 42, 2682\u20132688 (1999).","journal-title":"Arthritis Rheum."},{"key":"1290_CR3","first-page":"101938","volume":"37","author":"M Piga","year":"2023","unstructured":"Piga, M. et al. Clinical patterns of disease: from early systemic lupus erythematosus to late-onset disease. Best practice & research. Clin. Rheumatol. 37, 101938 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0961203310388445","volume":"20","author":"N Ruperto","year":"2011","unstructured":"Ruperto, N. et al. International consensus for a definition of disease flare in lupus. Lupus 20, 453\u2013462 (2011).","journal-title":"Lupus"},{"key":"1290_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/acr.23794","volume":"71","author":"DS Pisetsky","year":"2019","unstructured":"Pisetsky, D. S., Clowse, M. E. B., Criscione-Schreiber, L. G. & Rogers, J. L. A novel system to categorize the symptoms of systemic lupus erythematosus. Arthritis Care Res. 71, 735\u2013741 (2019).","journal-title":"Arthritis Care Res."},{"key":"1290_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/art.43152","volume":"77","author":"DS Pisetsky","year":"2025","unstructured":"Pisetsky, D. S. et al. Nociplasticity: a proposed concept to understand the symptomatology of systemic lupus erythematosus. Arthritis Rheumatol. 77, 966\u2013970 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1290_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","volume":"402","author":"G Schett","year":"2023","unstructured":"Schett, G., Mackensen, A. & Mougiakakos, D. CAR T-cell therapy in autoimmune diseases. Lancet 402, 2034\u20132044 (2023).","journal-title":"Lancet"},{"key":"1290_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","volume":"16","author":"DS Pisetsky","year":"2020","unstructured":"Pisetsky, D. S. & Lipsky, P. E. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 16, 565\u2013579 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1290_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","volume":"12","author":"DS Pisetsky","year":"2016","unstructured":"Pisetsky, D. S. Anti-DNA antibodies-quintessential biomarkers of SLE. Nat. Rev. Rheumatol. 12, 102\u2013110 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1290_CR10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3389\/fimmu.2019.01028","volume":"10","author":"T Mustelin","year":"2019","unstructured":"Mustelin, T., Lood, C. & Giltiay, N. V. Sources of pathogenic nucleic acids in systemic lupus erythematosus. Front. Immunol. 10, 1028 (2019).","journal-title":"Front. Immunol."},{"key":"1290_CR11","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fimmu.2019.01601","volume":"10","author":"C Soni","year":"2019","unstructured":"Soni, C. & Reizis, B. Self-DNA at the epicenter of SLE: immunogenic forms, regulation, and effects. Front. Immunol. 10, 1601 (2019).","journal-title":"Front. Immunol."},{"key":"1290_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000270","volume":"6","author":"L R\u00f6nnblom","year":"2019","unstructured":"R\u00f6nnblom, L. & Leonard, D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci. Med. 6, e000270 (2019).","journal-title":"Lupus Sci. Med."},{"key":"1290_CR13","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.4049\/jimmunol.163.11.6306","volume":"163","author":"H Vallin","year":"1999","unstructured":"Vallin, H., Perers, A., Alm, G. V. & R\u00f6nnblom, L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 163, 6306\u20136313 (1999).","journal-title":"J. Immunol."},{"key":"1290_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-052814-023338","volume":"67","author":"FJ Barrat","year":"2016","unstructured":"Barrat, F. J., Elkon, K. B. & Fitzgerald, K. A. Importance of nucleic acid recognition in inflammation and autoimmunity. Annu. Rev. Med. 67, 323\u2013336 (2016).","journal-title":"Annu. Rev. Med."},{"key":"1290_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clinbiochem.2012.12.004","volume":"46","author":"AA Venner","year":"2013","unstructured":"Venner, A. A. et al. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity. Clin. Biochem. 46, 317\u2013320 (2013).","journal-title":"Clin. Biochem."},{"key":"1290_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","volume":"23","author":"A Weinstein","year":"2021","unstructured":"Weinstein, A., Alexander, R. V. & Zack, D. J. A review of complement activation in SLE. Curr. Rheumatol. Rep. 23, 16 (2021).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1290_CR17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-024-06909-4","volume":"43","author":"JL Rogers","year":"2024","unstructured":"Rogers, J. L. et al. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity. Clin. Rheumatol. 43, 1319\u20131326 (2024).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/art.10512","volume":"47","author":"GS Alarc\u00f3n","year":"2002","unstructured":"Alarc\u00f3n, G. S. et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. Arthritis Rheum. 47, 408\u2013413 (2002).","journal-title":"Arthritis Rheum."},{"key":"1290_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0961203317722412","volume":"27","author":"V Golder","year":"2018","unstructured":"Golder, V. et al. Discordance of patient and physician health status concerns in systemic lupus erythematosus. Lupus 27, 501\u2013506 (2018).","journal-title":"Lupus"},{"key":"1290_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum, A. I., Bautista, D. M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267\u2013284 (2009).","journal-title":"Cell"},{"key":"1290_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrn2947","volume":"11","author":"AJ Todd","year":"2010","unstructured":"Todd, A. J. Neuronal circuitry for pain processing in the dorsal horn. Nat. Rev. Neurosci. 11, 823\u2013836 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"1290_CR22","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/j.pain.0000000000000775","volume":"158","author":"RB Fillingim","year":"2017","unstructured":"Fillingim, R. B. Individual differences in pain: understanding the mosaic that makes pain personal. Pain 158, S11\u2013S18 (2017).","journal-title":"Pain"},{"key":"1290_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2020.05.024","volume":"107","author":"G Gilam","year":"2020","unstructured":"Gilam, G., Gross, J. J., Wager, T. D., Keefe, F. J. & Mackey, S. C. What is the relationship between pain and emotion? Bridging constructs and communities. Neuron 107, 17\u201321 (2020).","journal-title":"Neuron"},{"key":"1290_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105235","volume":"151","author":"AM Pinto","year":"2023","unstructured":"Pinto, A. M. et al. Neurophysiological and psychosocial mechanisms of fibromyalgia: a comprehensive review and call for an integrative model. Neurosci. Biobehav. Rev. 151, 105235 (2023).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1290_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0166-2236(02)02157-4","volume":"25","author":"F Porreca","year":"2002","unstructured":"Porreca, F., Ossipov, M. H. & Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319\u2013325 (2002).","journal-title":"Trends Neurosci."},{"key":"1290_CR26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41586-024-07816-z","volume":"632","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. Neural circuit basis of placebo pain relief. Nature 632, 1092\u20131100 (2024).","journal-title":"Nature"},{"key":"1290_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd4334","volume":"13","author":"RR Ji","year":"2014","unstructured":"Ji, R. R., Xu, Z. Z. & Gao, Y. J. Emerging targets in neuroinflammation-driven chronic pain. Nat. Rev. Drug. Discov. 13, 533\u2013548 (2014).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1290_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.tins.2020.07.008","volume":"43","author":"CR Donnelly","year":"2020","unstructured":"Donnelly, C. R., Chen, O. & Ji, R. R. How do sensory neurons sense danger signals? Trends Neurosci. 43, 822\u2013838 (2020).","journal-title":"Trends Neurosci."},{"key":"1290_CR29","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1073\/pnas.96.14.7723","volume":"96","author":"CJ Woolf","year":"1999","unstructured":"Woolf, C. J. & Costigan, M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc. Natl Acad. Sci. USA 96, 7723\u20137730 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1290_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nm.2235","volume":"16","author":"MS Gold","year":"2010","unstructured":"Gold, M. S. & Gebhart, G. F. Nociceptor sensitization in pain pathogenesis. Nat. Med. 16, 1248\u20131257 (2010).","journal-title":"Nat. Med."},{"key":"1290_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji, R. R., Nackley, A., Huh, Y., Terrando, N. & Maixner, W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 129, 343\u2013366 (2018).","journal-title":"Anesthesiology"},{"key":"1290_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis, A. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann. Rheum. Dis. 83, 15\u201329 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1290_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.berh.2009.04.003","volume":"23","author":"JM Grossman","year":"2009","unstructured":"Grossman, J. M. Lupus arthritis. Best. Pract. Res. Clin. Rheumatol. 23, 495\u2013506 (2009).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"1290_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0961203317747716","volume":"27","author":"A Di Matteo","year":"2018","unstructured":"Di Matteo, A., De Angelis, R., Cipolletta, E., Filippucci, E. & Grassi, W. Systemic lupus erythematosus arthropathy: the sonographic perspective. Lupus 27, 794\u2013801 (2018).","journal-title":"Lupus"},{"key":"1290_CR35","doi-asserted-by":"publisher","first-page":"101859","DOI":"10.1016\/j.berh.2023.101859","volume":"37","author":"A Shumilova","year":"2023","unstructured":"Shumilova, A. & Vital, E. M. Musculoskeletal manifestations of systemic lupus erythematosus. Best. Pract. Res. Clin. Rheumatol. 37, 101859 (2023).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"1290_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/rheumatology\/kead223","volume":"63","author":"P Corzo Garcia","year":"2024","unstructured":"Corzo Garcia, P. et al. Musculoskeletal involvement in systemic lupus erythematosus: a contrast-enhanced magnetic resonance imaging study in 107 subjects. Rheumatology 63, 423\u2013429 (2024).","journal-title":"Rheumatology"},{"key":"1290_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/BOR.0000000000001006","volume":"36","author":"G Steiner","year":"2024","unstructured":"Steiner, G. & Toes, R. E. M. Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond. Curr. Opin. Rheumatol. 36, 217\u2013224 (2024).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1290_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw, L. A., Rispens, T. & Toes, R. E. M. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 331\u2013339 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1290_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41418-023-01124-1","volume":"30","author":"J Singh","year":"2023","unstructured":"Singh, J. et al. Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ. 30, 861\u2013875 (2023).","journal-title":"Cell Death Differ."},{"key":"1290_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102612","volume":"19","author":"L Antonini","year":"2020","unstructured":"Antonini, L., Le Mauff, B., Marcelli, C., Aouba, A. & de Boysson, H. Rhupus: a systematic literature review. Autoimmun. Rev. 19, 102612 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1290_CR41","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/0961203320938456","volume":"29","author":"B Frade-Sosa","year":"2020","unstructured":"Frade-Sosa, B. et al. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. Lupus 29, 1216\u20131226 (2020).","journal-title":"Lupus"},{"key":"1290_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbi.2023.07.001","volume":"113","author":"A Jurczak","year":"2023","unstructured":"Jurczak, A. et al. Insights into Fc\u03b3R involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody. Brain Behav. Immun. 113, 212\u2013227 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1290_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","volume":"75","author":"G Wigerblad","year":"2016","unstructured":"Wigerblad, G. et al. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann. Rheum. Dis. 75, 730\u2013738 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1290_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/art.42320","volume":"75","author":"A Krishnamurthy","year":"2023","unstructured":"Krishnamurthy, A. et al. Combination of two monoclonal anti-citrullinated protein antibodies induced tenosynovitis, pain, and bone loss in mice in a peptidyl arginine deiminase-4-dependent manner. Arthritis Rheumatol. 75, 164\u2013170 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1290_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/ard-2022-223417","volume":"82","author":"B Raposo","year":"2023","unstructured":"Raposo, B. et al. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann. Rheum. Dis. 82, 724\u2013726 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1290_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36257-x","volume":"14","author":"Y He","year":"2023","unstructured":"He, Y. et al. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. Nat. Commun. 14, 691 (2023).","journal-title":"Nat. Commun."},{"key":"1290_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj1277","volume":"16","author":"MJ Lacagnina","year":"2024","unstructured":"Lacagnina, M. J. et al. B cells drive neuropathic pain-related behaviors in mice through IgG-Fc gamma receptor signaling. Sci. Transl. Med. 16, eadj1277 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1290_CR48","doi-asserted-by":"publisher","first-page":"eadk3506","DOI":"10.1126\/scitranslmed.adk3506","volume":"16","author":"Z Bai","year":"2024","unstructured":"Bai, Z. et al. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis. Sci. Transl. Med. 16, eadk3506 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1290_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ard.2025.01.005","volume":"84","author":"N Simon","year":"2025","unstructured":"Simon, N. et al. Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse model. Ann. Rheum. Dis. 84, 421\u2013434 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1290_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74391-4","volume":"10","author":"EL Hubbard","year":"2020","unstructured":"Hubbard, E. L. et al. Analysis of gene expression from systemic lupus erythematosus synovium reveals myeloid cell-driven pathogenesis of lupus arthritis. Sci. Rep. 10, 17361 (2020).","journal-title":"Sci. Rep."},{"key":"1290_CR51","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.22578","volume":"56","author":"A Nzeusseu Toukap","year":"2007","unstructured":"Nzeusseu Toukap, A. et al. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 56, 1579\u20131588 (2007).","journal-title":"Arthritis Rheum."},{"key":"1290_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-016-0608-6","volume":"18","author":"S Kasturi","year":"2016","unstructured":"Kasturi, S. & Goodman, S. Current perspectives on arthroplasty in systemic lupus erythematosus: rates, outcomes, and adverse events. Curr. Rheumatol. Rep. 18, 59 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1290_CR53","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1177\/09612033211021166","volume":"30","author":"Y Long","year":"2021","unstructured":"Long, Y. et al. Risk of osteonecrosis in systemic lupus erythematosus: an 11-year Chinese single-center cohort study. Lupus 30, 1459\u20131468 (2021).","journal-title":"Lupus"},{"key":"1290_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152444","volume":"66","author":"R Dhital","year":"2024","unstructured":"Dhital, R. et al. Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis. Semin. Arthritis Rheum. 66, 152444 (2024).","journal-title":"Semin. Arthritis Rheum."},{"key":"1290_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100168","volume":"5","author":"F Motta","year":"2022","unstructured":"Motta, F., Timilsina, S., Gershwin, M. E. & Selmi, C. Steroid-induced osteonecrosis. J. Transl. Autoimmun. 5, 100168 (2022).","journal-title":"J. Transl. Autoimmun."},{"key":"1290_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41582-024-00966-8","volume":"20","author":"CM Kaplan","year":"2024","unstructured":"Kaplan, C. M. et al. Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms. Nat. Rev. Neurol. 20, 347\u2013363 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1290_CR57","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles, M. A. et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397, 2098\u20132110 (2021).","journal-title":"Lancet"},{"key":"1290_CR58","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf, C. J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2\u2013S15 (2011).","journal-title":"Pain"},{"key":"1290_CR59","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","volume":"162","author":"E Kosek","year":"2021","unstructured":"Kosek, E. et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162, 2629\u20132634 (2021).","journal-title":"Pain"},{"key":"1290_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/03010066241234037","volume":"53","author":"C Rafferty","year":"2024","unstructured":"Rafferty, C. & Ward, J. Fibromyalgia is linked to increased subjective sensory sensitivity across multiple senses. Perception 53, 276\u2013286 (2024).","journal-title":"Perception"},{"key":"1290_CR61","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jpain.2021.02.009","volume":"22","author":"R Staud","year":"2021","unstructured":"Staud, R., Godfrey, M. M. & Robinson, M. E. Fibromyalgia patients are not only hypersensitive to painful stimuli but also to acoustic stimuli. J. Pain\u00a022, 914\u2013925 (2021).","journal-title":"J. Pain"},{"key":"1290_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/j.pain.0000000000000707","volume":"158","author":"M L\u00f3pez-Sol\u00e0","year":"2017","unstructured":"L\u00f3pez-Sol\u00e0, M. et al. Towards a neurophysiological signature for fibromyalgia. Pain 158, 34\u201347 (2017).","journal-title":"Pain"},{"key":"1290_CR63","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/art.1780370812","volume":"37","author":"GD Middleton","year":"1994","unstructured":"Middleton, G. D., McFarlin, J. E. & Lipsky, P. E. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 37, 1181\u20131188 (1994).","journal-title":"Arthritis Rheum."},{"key":"1290_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10067-024-07188-9","volume":"44","author":"S Mistry","year":"2025","unstructured":"Mistry, S., Daoud, A., Magrey, M. N. & Pamuk, O. N. The frequency of fibromyalgia in patients with systemic lupus erythematosus and associated factors: a systematic review and meta-analysis. Clin. Rheumatol. 44, 9\u201321 (2025).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR65","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11926-006-0037-z","volume":"8","author":"R Staud","year":"2006","unstructured":"Staud, R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr. Rheumatol. Rep. 8, 430\u2013435 (2006).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1290_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3899\/jrheum.090781","volume":"37","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F., Michaud, K., Li, T. & Katz, R. S. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J. Rheumatol. 37, 305\u2013315 (2010).","journal-title":"J. Rheumatol."},{"key":"1290_CR67","doi-asserted-by":"publisher","first-page":"T93","DOI":"10.1016\/j.jpain.2016.06.002","volume":"17","author":"W Maixner","year":"2016","unstructured":"Maixner, W., Fillingim, R. B., Williams, D. A., Smith, S. B. & Slade, G. D. Overlapping chronic pain conditions: implications for diagnosis and classification. J. Pain\u00a017, T93\u2013T107 (2016).","journal-title":"J. Pain"},{"key":"1290_CR68","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/acr.25104","volume":"75","author":"AE Murphy","year":"2023","unstructured":"Murphy, A. E., Minhas, D., Clauw, D. J. & Lee, Y. C. Identifying and managing nociplastic pain in individuals with rheumatic diseases: a narrative review. Arthritis Care Res. 75, 2215\u20132222 (2023).","journal-title":"Arthritis Care Res."},{"key":"1290_CR69","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/art.43049","volume":"77","author":"CF Meng","year":"2025","unstructured":"Meng, C. F. et al. Characterizing nonarticular pain at early rheumatoid arthritis diagnosis: evolution over the first year of treatment and impact on remission in a prospective real-world early rheumatoid arthritis cohort. Arthritis Rheumatol. 77, 405\u2013413 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1290_CR70","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/rheumatology\/kez303","volume":"59","author":"A Schrepf","year":"2020","unstructured":"Schrepf, A. et al. Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement. Rheumatology 59, 594\u2013602 (2020).","journal-title":"Rheumatology"},{"key":"1290_CR71","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12529-023-10249-z","volume":"31","author":"KE Gnall","year":"2024","unstructured":"Gnall, K. E. et al. Changes in interoception in mind-body therapies for chronic pain: a systematic review and meta-analysis. Int. J. Behav. Med. 31, 833\u2013847 (2024).","journal-title":"Int. J. Behav. Med."},{"key":"1290_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2024.108761","volume":"186","author":"J Todd","year":"2024","unstructured":"Todd, J. et al. Heightened interoception in adults with fibromyalgia. Biol. Psychol. 186, 108761 (2024).","journal-title":"Biol. Psychol."},{"key":"1290_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fnhum.2017.00117","volume":"11","author":"C Valenzuela-Moguillansky","year":"2017","unstructured":"Valenzuela-Moguillansky, C., Reyes-Reyes, A. & Gaete, M. I. Exteroceptive and interoceptive body-self awareness in fibromyalgia patients. Front. Hum. Neurosci. 11, 117 (2017).","journal-title":"Front. Hum. Neurosci."},{"key":"1290_CR74","doi-asserted-by":"publisher","first-page":"T75","DOI":"10.1016\/j.jpain.2013.06.009","volume":"14","author":"RB Fillingim","year":"2013","unstructured":"Fillingim, R. B. et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J. Pain\u00a014, T75\u2013T90 (2013).","journal-title":"J. Pain"},{"key":"1290_CR75","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/acr2.11488","volume":"4","author":"T Falasinnu","year":"2022","unstructured":"Falasinnu, T. et al. The problem of pain in rheumatology: clinical profiles associated with concomitant diagnoses with chronic overlapping pain conditions. ACR Open. Rheumatol. 4, 890\u2013896 (2022).","journal-title":"ACR Open. Rheumatol."},{"key":"1290_CR76","doi-asserted-by":"crossref","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42, 599\u2013608 (1999).","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"1290_CR77","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.38302","volume":"66","author":"A Oomatia","year":"2014","unstructured":"Oomatia, A., Fang, H., Petri, M. & Birnbaum, J. Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheumatol. 66, 1000\u20131009 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1290_CR78","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jns.12644","volume":"29","author":"E Galosi","year":"2024","unstructured":"Galosi, E. et al. Clinical, histologic, and immunologic signatures of small fiber neuropathy in systemic lupus erythematosus. J. Peripher. Nerv. Syst. 29, 315\u2013328 (2024).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1290_CR79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2011.04.001","volume":"41","author":"B Florica","year":"2011","unstructured":"Florica, B. et al. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin. Arthritis Rheum. 41, 203\u2013211 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"1290_CR80","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria, G. et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher. Nerv. Syst. 15, 202\u2013207 (2010).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1290_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathophysiology29010001","volume":"29","author":"MV Lukashenko","year":"2021","unstructured":"Lukashenko, M. V. et al. Corneal confocal microscopy in the diagnosis of small fiber neuropathy: faster, easier, and more efficient than skin biopsy? Pathophysiology 29, 1\u20138 (2021).","journal-title":"Pathophysiology"},{"key":"1290_CR82","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.semarthrit.2018.08.003","volume":"48","author":"R Grayston","year":"2019","unstructured":"Grayston, R. et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin. Arthritis Rheum. 48, 933\u2013940 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"1290_CR83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/AJP.0000000000001085","volume":"39","author":"A Dumolard","year":"2023","unstructured":"Dumolard, A. et al. Central sensitization and small-fiber neuropathy are associated in patients with fibromyalgia. Clin. J. Pain\u00a039, 8\u201314 (2023).","journal-title":"Clin. J. Pain"},{"key":"1290_CR84","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001136","volume":"9","author":"S J\u00e4nsch","year":"2024","unstructured":"J\u00e4nsch, S. et al. Distinguishing fibromyalgia syndrome from small fiber neuropathy: a clinical guide. Pain. Rep. 9, e1136 (2024).","journal-title":"Pain. Rep."},{"key":"1290_CR85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/WCO.0000000000001103","volume":"35","author":"JGJ Hoeijmakers","year":"2022","unstructured":"Hoeijmakers, J. G. J., Merkies, I. S. J. & Faber, C. G. Small fiber neuropathies: expanding their etiologies. Curr. Opin. Neurol. 35, 545\u2013552 (2022).","journal-title":"Curr. Opin. Neurol."},{"key":"1290_CR86","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer, R., O\u2019Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46\u201356 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"1290_CR87","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0889-1591(02)00077-6","volume":"17","author":"KW Kelley","year":"2003","unstructured":"Kelley, K. W. et al. Cytokine-induced sickness behavior. Brain, Behav., Immun. 17, S112\u2013S118 (2003).","journal-title":"Brain, Behav., Immun."},{"key":"1290_CR88","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","volume":"27","author":"S Sleijfer","year":"2005","unstructured":"Sleijfer, S., Bannink, M., Van Gool, A. R., Kruit, W. H. & Stoter, G. Side effects of interferon-\u0251 therapy. Pharm. World Sci. 27, 423\u2013431 (2005).","journal-title":"Pharm. World Sci."},{"key":"1290_CR89","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1177\/09612033211049305","volume":"30","author":"L Gimeno-Torres","year":"2021","unstructured":"Gimeno-Torres, L. et al. Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a case-control study. Lupus 30, 2095\u20132101 (2021).","journal-title":"Lupus"},{"key":"1290_CR90","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s10067-024-07189-8","volume":"43","author":"W Louthrenoo","year":"2024","unstructured":"Louthrenoo, W. et al. Clinical features, imaging findings, and outcomes of acute abdominal pain in systemic lupus erythematosus: comparing mesenteric vasculitis, non-mesenteric vasculitis, and surgical conditions. Clin. Rheumatol. 43, 3699\u20133712 (2024).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152566","volume":"69","author":"J Feld","year":"2024","unstructured":"Feld, J., Tayer-Shifman, O. E., Su, J., Anderson, M. & Touma, Z. Primary headache in SLE -systematic review and meta-analysis. Semin. Arthritis Rheum. 69, 152566 (2024).","journal-title":"Semin. Arthritis Rheum."},{"key":"1290_CR92","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1002\/art.38106","volume":"65","author":"JG Hanly","year":"2013","unstructured":"Hanly, J. G. et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum. 65, 2887\u20132897 (2013).","journal-title":"Arthritis Rheum."},{"key":"1290_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000444","volume":"8","author":"D Yan","year":"2021","unstructured":"Yan, D. et al. Cutaneous lupus concerns from the patient perspective: a qualitative study. Lupus Sci. Med. 8, e000444 (2021).","journal-title":"Lupus Sci. Med."},{"key":"1290_CR94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3899\/jrheum.220089","volume":"50","author":"C Stull","year":"2023","unstructured":"Stull, C., Sprow, G. & Werth, V. P. Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist. J. Rheumatol. 50, 27\u201335 (2023).","journal-title":"J. Rheumatol."},{"key":"1290_CR95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.21037\/atm-20-4894","volume":"9","author":"HJ Kim","year":"2021","unstructured":"Kim, H. J. Pruritus in autoimmune connective tissue diseases. Ann. Transl. Med. 9, 441 (2021).","journal-title":"Ann. Transl. Med."},{"key":"1290_CR96","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/09612033211016098","volume":"30","author":"D Samotij","year":"2021","unstructured":"Samotij, D. et al. Clinical characteristics of itch in cutaneous lupus erythematosus: a prospective, multicenter, multinational, cross-sectional study. Lupus 30, 1385\u20131393 (2021).","journal-title":"Lupus"},{"key":"1290_CR97","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/art.24553","volume":"61","author":"F Wolfe","year":"2009","unstructured":"Wolfe, F. Fibromyalgianess. Arthritis Rheum. 61, 715\u2013716 (2009).","journal-title":"Arthritis Rheum."},{"key":"1290_CR98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3899\/jrheum.080212","volume":"36","author":"F Wolfe","year":"2009","unstructured":"Wolfe, F. et al. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity. J. Rheumatol. 36, 82\u201388 (2009).","journal-title":"J. Rheumatol."},{"key":"1290_CR99","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/acr.24135","volume":"73","author":"JL Rogers","year":"2021","unstructured":"Rogers, J. L. et al. Using clinical characteristics and patient-reported outcome measures to categorize systemic lupus erythematosus subtypes. Arthritis Care Res. 73, 386\u2013393 (2021).","journal-title":"Arthritis Care Res."},{"key":"1290_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000861","volume":"10","author":"R Robl","year":"2023","unstructured":"Robl, R. et al. Molecular endotypes of type 1 and type 2 SLE. Lupus Sci. Med. 10, e000861 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1290_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114057","volume":"43","author":"LF Condon","year":"2024","unstructured":"Condon, L. F. et al. Parabrachial calca neurons drive nociplasticity. Cell Rep. 43, 114057 (2024).","journal-title":"Cell Rep."},{"key":"1290_CR102","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","volume":"57","author":"SJ Duffield","year":"2018","unstructured":"Duffield, S. J., Miller, N., Zhao, S. & Goodson, N. J. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology 57, 1453\u20131460 (2018).","journal-title":"Rheumatology"},{"key":"1290_CR103","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0961203320919872","volume":"29","author":"LP Nichilatti","year":"2020","unstructured":"Nichilatti, L. P., Fernandes, J. M. & Marques, C. P. Physiopathology of pain in systemic erythematosus lupus. Lupus 29, 721\u2013726 (2020).","journal-title":"Lupus"},{"key":"1290_CR104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.rdc.2020.12.004","volume":"47","author":"DS Pisetsky","year":"2021","unstructured":"Pisetsky, D. S., Eudy, A. M., Clowse, M. E. B. & Rogers, J. L. The categorization of pain in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 47, 215\u2013228 (2021).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"1290_CR105","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.2023-0721","volume":"51","author":"JL Rogers","year":"2024","unstructured":"Rogers, J. L. et al. Patient and physician perspectives of systemic lupus erythematosus flare: a qualitative study. J. Rheumatol. 51, 488\u2013494 (2024).","journal-title":"J. Rheumatol."},{"key":"1290_CR106","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.socscimed.2007.07.003","volume":"66","author":"D Album","year":"2008","unstructured":"Album, D. & Westin, S. Do diseases have a prestige hierarchy? A survey among physicians and medical students. Soc. Sci. Med. 66, 182\u2013188 (2008).","journal-title":"Soc. Sci. Med."},{"key":"1290_CR107","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/jan.14394","volume":"76","author":"LEF Johannessen","year":"2020","unstructured":"Johannessen, L. E. F., Album, D. & Rasmussen, E. B. Do nurses rate diseases according to prestige? A survey study. J. Adv. Nurs. 76, 1691\u20131697 (2020).","journal-title":"J. Adv. Nurs."},{"key":"1290_CR108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","volume":"33","author":"M Matsuda","year":"2019","unstructured":"Matsuda, M., Huh, Y. & Ji, R. R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J. Anesth. 33, 131\u2013139 (2019).","journal-title":"J. Anesth."},{"key":"1290_CR109","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7152","volume":"13","author":"A Kavelaars","year":"2021","unstructured":"Kavelaars, A. & Heijnen, C. J. Immune regulation of pain: friend and foe. Sci. Transl. Med. 13, eabj7152 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1290_CR110","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat, R. et al. Neuroinflammation and depression: a review. Eur. J. Neurosci. 53, 151\u2013171 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"1290_CR111","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41584-023-01037-w","volume":"19","author":"J Brock","year":"2023","unstructured":"Brock, J. et al. Immune mechanisms of depression in rheumatoid arthritis. Nat. Rev. Rheumatol. 19, 790\u2013804 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1290_CR112","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/kez346","volume":"58","author":"KL Druce","year":"2019","unstructured":"Druce, K. L. & Basu, N. Predictors of fatigue in rheumatoid arthritis. Rheumatology 58, v29\u2013v34 (2019).","journal-title":"Rheumatology"},{"key":"1290_CR113","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13075-020-02180-5","volume":"22","author":"C Ol\u00e1h","year":"2020","unstructured":"Ol\u00e1h, C. et al. Cognitive dysfunction in autoimmune rheumatic diseases. Arthritis Res. Ther. 22, 78 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"1290_CR114","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000905","volume":"6","author":"MJ Lacagnina","year":"2021","unstructured":"Lacagnina, M. J., Heijnen, C. J., Watkins, L. R. & Grace, P. M. Autoimmune regulation of chronic pain. Pain. Rep. 6, e905 (2021).","journal-title":"Pain. Rep."},{"key":"1290_CR115","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001167","volume":"9","author":"R Mountford","year":"2024","unstructured":"Mountford, R. et al. Antibody-mediated autoimmunity in symptom-based disorders: position statement and proceedings from an international workshop. Pain. Rep. 9, e1167 (2024).","journal-title":"Pain. Rep."},{"key":"1290_CR116","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbi.2025.01.015","volume":"125","author":"NT Fiore","year":"2025","unstructured":"Fiore, N. T. et al. Reducing IgG accumulation via neonatal Fc receptor (FcRn) blockade relieves neuropathic pain. Brain, Behav., Immun. 125, 371\u2013387 (2025).","journal-title":"Brain, Behav., Immun."},{"key":"1290_CR117","doi-asserted-by":"publisher","unstructured":"Berwick, R. J. et al. Postacute COVID-19 syndrome and fibromyalgia syndrome are associated with anti-satellite glial cell IgG serum autoantibodies but only fibromyalgia syndrome serum-IgG is pronociceptive. Pain. https:\/\/doi.org\/10.1097\/j.pain.0000000000003629 (2025).","DOI":"10.1097\/j.pain.0000000000003629"},{"key":"1290_CR118","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144201","volume":"131","author":"A Goebel","year":"2021","unstructured":"Goebel, A. et al. Passive transfer of fibromyalgia symptoms from patients to mice. J. Clin. Invest. 131, e144201 (2021).","journal-title":"J. Clin. Invest."},{"key":"1290_CR119","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbi.2023.09.003","volume":"114","author":"S Fanton","year":"2023","unstructured":"Fanton, S. et al. Anti-satellite glia cell IgG antibodies in fibromyalgia patients are related to symptom severity and to metabolite concentrations in thalamus and rostral anterior cingulate cortex. Brain, Behav., Immun. 114, 371\u2013382 (2023).","journal-title":"Brain, Behav., Immun."},{"key":"1290_CR120","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/j.pain.0000000000002881","volume":"164","author":"E Krock","year":"2023","unstructured":"Krock, E. et al. Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms. Pain 164, 1828\u20131840 (2023).","journal-title":"Pain"},{"key":"1290_CR121","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/j.pain.0000000000003535","volume":"166","author":"S Seefried","year":"2025","unstructured":"Seefried, S. et al. Autoantibodies in patients with fibromyalgia syndrome. Pain 166, 1922\u20131933 (2025).","journal-title":"Pain"},{"key":"1290_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454747","volume":"15","author":"WH Robinson","year":"2024","unstructured":"Robinson, W. H. et al. Cutting-edge approaches to B-cell depletion in autoimmune diseases. Front. Immunol. 15, 1454747 (2024).","journal-title":"Front. Immunol."},{"key":"1290_CR123","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1084\/jem.20180776","volume":"215","author":"J Nestor","year":"2018","unstructured":"Nestor, J. et al. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J. Exp. Med. 215, 2554\u20132566 (2018).","journal-title":"J. Exp. Med."},{"key":"1290_CR124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11926-021-00992-1","volume":"23","author":"A Zarfeshani","year":"2021","unstructured":"Zarfeshani, A., Carroll, K. R., Volpe, B. T. & Diamond, B. Cognitive impairment in SLE: mechanisms and therapeutic approaches. Curr. Rheumatol. Rep. 23, 25 (2021).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1290_CR125","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.it.2015.09.008","volume":"36","author":"L Brimberg","year":"2015","unstructured":"Brimberg, L. et al. Antibodies as mediators of brain pathology. Trends Immunol. 36, 709\u2013724 (2015).","journal-title":"Trends Immunol."},{"key":"1290_CR126","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41590-024-01772-6","volume":"25","author":"KR Carroll","year":"2024","unstructured":"Carroll, K. R. et al. Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression. Nat. Immunol. 25, 671\u2013681 (2024).","journal-title":"Nat. Immunol."},{"key":"1290_CR127","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/art.40746","volume":"71","author":"KT Martucci","year":"2019","unstructured":"Martucci, K. T., Weber, K. A. 2nd & Mackey, S. C. Altered cervical spinal cord resting-state activity in fibromyalgia. Arthritis Rheumatol. 71, 441\u2013450 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1290_CR128","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1097\/j.pain.0000000000002973","volume":"164","author":"I Mawla","year":"2023","unstructured":"Mawla, I. et al. Large-scale momentary brain co-activation patterns are associated with hyperalgesia and mediate focal neurochemistry and cross-network functional connectivity in fibromyalgia. Pain 164, 2737\u20132748 (2023).","journal-title":"Pain"},{"key":"1290_CR129","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/ejp.832","volume":"20","author":"E Ichesco","year":"2016","unstructured":"Ichesco, E. et al. Altered fMRI resting-state connectivity in individuals with fibromyalgia on acute pain stimulation. Eur. J. Pain 20, 1079\u20131089 (2016).","journal-title":"Eur. J. Pain"},{"key":"1290_CR130","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","volume":"33","author":"M Mackay","year":"2020","unstructured":"Mackay, M., Tang, C. C. & Vo, A. Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus. Curr. Opin. Neurol. 33, 353\u2013361 (2020).","journal-title":"Curr. Opin. Neurol."},{"key":"1290_CR131","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/rheumatology\/kez132","volume":"58","author":"N Basu","year":"2019","unstructured":"Basu, N. et al. Functional and structural magnetic resonance imaging correlates of fatigue in patients with rheumatoid arthritis. Rheumatology 58, 1822\u20131830 (2019).","journal-title":"Rheumatology"},{"key":"1290_CR132","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fpsyt.2019.00754","volume":"10","author":"D Iancheva","year":"2019","unstructured":"Iancheva, D., Trenova, A., Mantarova, S. & Terziyski, K. Functional magnetic resonance imaging correlations between fatigue and cognitive performance in patients with relapsing remitting multiple sclerosis. Front. Psychiatry 10, 754 (2019).","journal-title":"Front. Psychiatry"},{"key":"1290_CR133","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41591-024-02839-5","volume":"30","author":"S Toikumo","year":"2024","unstructured":"Toikumo, S. et al. A multi-ancestry genetic study of pain intensity in 598,339 veterans. Nat. Med. 30, 1075\u20131084 (2024).","journal-title":"Nat. Med."},{"key":"1290_CR134","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrrheum.2013.43","volume":"9","author":"L Diatchenko","year":"2013","unstructured":"Diatchenko, L., Fillingim, R. B., Smith, S. B. & Maixner, W. The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nat. Rev. Rheumatol. 9, 340\u2013350 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1290_CR135","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jns.12590","volume":"28","author":"JH Yuan","year":"2023","unstructured":"Yuan, J. H. et al. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders. J. Peripher. Nerv. Syst. 28, 597\u2013607 (2023).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1290_CR136","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.trsl.2022.07.004","volume":"251","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Single-cell RNA sequencing in the context of neuropathic pain: progress, challenges, and prospects. Transl. Res. 251, 96\u2013103 (2023).","journal-title":"Transl. Res."},{"key":"1290_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28473-8","volume":"13","author":"S Tansley","year":"2022","unstructured":"Tansley, S. et al. Single-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain. Nat. Commun. 13, 843 (2022).","journal-title":"Nat. Commun."},{"key":"1290_CR138","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001526","volume":"12","author":"E Hubbard","year":"2025","unstructured":"Hubbard, E., Bachali, P., Grammer, A. C. & Lipsky, P. E. Validation of eight endotypes of lupus based on whole-blood RNA profiles. Lupus Sci. Med. 12, e001526 (2025).","journal-title":"Lupus Sci. Med."},{"key":"1290_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102359","volume":"110","author":"MD Catalina","year":"2020","unstructured":"Catalina, M. D., Owen, K. A., Labonte, A. C., Grammer, A. C. & Lipsky, P. E. The pathogenesis of systemic lupus erythematosus: harnessing big data to understand the molecular basis of lupus. J. Autoimmun. 110, 102359 (2020).","journal-title":"J. Autoimmun."},{"key":"1290_CR140","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7180","volume":"13","author":"E Navratilova","year":"2021","unstructured":"Navratilova, E., Fillingim, R. B. & Porreca, F. Sexual dimorphism in functional pain syndromes. Sci. Transl. Med. 13, eabj7180 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1290_CR141","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211487","volume":"219","author":"N Jiwrajka","year":"2022","unstructured":"Jiwrajka, N. & Anguera, M. C. The X in seX-biased immunity and autoimmune rheumatic disease. J. Exp. Med. 219, e20211487 (2022).","journal-title":"J. Exp. Med."},{"key":"1290_CR142","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.22375","volume":"56","author":"RM Andrade","year":"2007","unstructured":"Andrade, R. M. et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 56, 622\u2013630 (2007).","journal-title":"Arthritis Rheum."},{"key":"1290_CR143","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/acr.23588","volume":"71","author":"M Jolly","year":"2019","unstructured":"Jolly, M. et al. Sex differences in quality of life in patients with systemic lupus erythematosus. Arthritis Care Res. 71, 1647\u20131652 (2019).","journal-title":"Arthritis Care Res."},{"key":"1290_CR144","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/09612033241301176","volume":"34","author":"TE Jiang","year":"2025","unstructured":"Jiang, T. E., Mackey, S., Darnall, B. D., Simard, J. F. & Falasinnu, T. The problem of pain in systemic lupus erythematosus: a comprehensive analysis of pain distribution using the CHOIR body map and PROMIS measures. Lupus 34, 47\u201356 (2025).","journal-title":"Lupus"},{"key":"1290_CR145","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/BOR.0000000000000929","volume":"35","author":"D Minhas","year":"2023","unstructured":"Minhas, D., Murphy, A. & Clauw, D. J. Fibromyalgia and centralized pain in the rheumatoid arthritis patient. Curr. Opin. Rheumatol. 35, 170\u2013174 (2023).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1290_CR146","first-page":"1141","volume":"42","author":"M Di Carlo","year":"2024","unstructured":"Di Carlo, M. et al. Fibromyalgia: one year in review 2024. Clin. Exp. Rheumatol. 42, 1141\u20131149 (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1290_CR147","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fncel.2018.00035","volume":"12","author":"OC Eller-Smith","year":"2018","unstructured":"Eller-Smith, O. C., Nicol, A. L. & Christianson, J. A. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front. Cell. Neurosci. 12, 35 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"1290_CR148","doi-asserted-by":"publisher","unstructured":"Aringer M., & Pisetsky D. S. The dynamics of antinuclear antibody production in systemic lupus erythematosus: new insights for new therapies. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.43220 (2025).","DOI":"10.1002\/art.43220"},{"key":"1290_CR149","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001016","volume":"10","author":"MEB Clowse","year":"2023","unstructured":"Clowse, M. E. B. et al. Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms. Lupus Sci. Med. 10, e001016 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1290_CR150","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10067-020-05528-z","volume":"40","author":"M Mart\u00ednez-Lav\u00edn","year":"2021","unstructured":"Mart\u00ednez-Lav\u00edn, M. Dorsal root ganglia: fibromyalgia pain factory? Clin. Rheumatol. 40, 783\u2013787 (2021).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR151","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji, R. R., Chamessian, A. & Zhang, Y. Q. Pain regulation by non-neuronal cells and inflammation. Science 354, 572\u2013577 (2016).","journal-title":"Science"},{"key":"1290_CR152","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuron.2014.02.011","volume":"82","author":"CK Park","year":"2014","unstructured":"Park, C. K. et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82, 47\u201354 (2014).","journal-title":"Neuron"},{"key":"1290_CR153","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann, S. M. et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827\u2013835 (2012).","journal-title":"Nat. Neurosci."},{"key":"1290_CR154","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895\u2013926 (2009).","journal-title":"J. Pain"},{"key":"1290_CR155","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/ALN.0000000000002137","volume":"128","author":"KT Martucci","year":"2018","unstructured":"Martucci, K. T. & Mackey, S. C. Neuroimaging of pain: human evidence and clinical relevance of central nervous system processes and modulation. Anesthesiology 128, 1241\u20131254 (2018).","journal-title":"Anesthesiology"},{"key":"1290_CR156","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 46, 319\u2013329 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"1290_CR157","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3899\/jrheum.141519","volume":"42","author":"F Wolfe","year":"2015","unstructured":"Wolfe, F., Walitt, B. T., Rasker, J. J., Katz, R. S. & H\u00e4user, W. The use of polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity. J. Rheumatol. 42, 1494\u20131501 (2015).","journal-title":"J. Rheumatol."},{"key":"1290_CR158","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s41687-023-00678-5","volume":"7","author":"K Sun","year":"2023","unstructured":"Sun, K. et al. Using PROMIS-29 to determine symptom burdens in the context of the type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study. J. Patient Rep. Outcomes 7, 136 (2023).","journal-title":"J. Patient Rep. Outcomes"},{"key":"1290_CR159","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jval.2014.09.005","volume":"17","author":"BM Craig","year":"2014","unstructured":"Craig, B. M. et al. US valuation of health outcomes measured using the PROMIS-29. Value Health 17, 846\u2013853 (2014).","journal-title":"Value Health"},{"key":"1290_CR160","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jclinepi.2010.11.018","volume":"64","author":"KJ Yost","year":"2011","unstructured":"Yost, K. J., Eton, D. T., Garcia, S. F. & Cella, D. Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. J. Clin. Epidemiol. 64, 507\u2013516 (2011).","journal-title":"J. Clin. Epidemiol."},{"key":"1290_CR161","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s10067-023-06525-8","volume":"42","author":"R Arcani","year":"2023","unstructured":"Arcani, R., Jouve, E., Chiche, L. & Jourde-Chiche, N. Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures. Clin. Rheumatol. 42, 1555\u20131563 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1290_CR162","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/09612033221090885","volume":"31","author":"AM Eudy","year":"2022","unstructured":"Eudy, A. M. et al. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity. Lupus 31, 697\u2013705 (2022).","journal-title":"Lupus"},{"key":"1290_CR163","first-page":"53","volume":"19","author":"M Petri","year":"1992","unstructured":"Petri, M., Hellmann, D. & Hochberg, M. Validity and reliability of lupus activity measures in the routine clinic setting. J. Rheumatol. 19, 53\u201359 (1992).","journal-title":"J. Rheumatol."},{"key":"1290_CR164","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon, J. P. et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142, 953\u2013962 (2005).","journal-title":"Ann. Intern. Med."},{"key":"1290_CR165","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/j.pain.0000000000003184","volume":"165","author":"DJ Clauw","year":"2024","unstructured":"Clauw, D. J. Why don\u2019t we use a body map in every chronic pain patient yet? Pain 165, 1660\u20131661 (2024).","journal-title":"Pain"},{"key":"1290_CR166","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000880","volume":"6","author":"KH Scherrer","year":"2021","unstructured":"Scherrer, K. H. et al. Development and validation of the collaborative health outcomes information registry body map. Pain. Rep. 6, e880 (2021).","journal-title":"Pain. Rep."},{"key":"1290_CR167","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/j.pain.0000000000000506","volume":"157","author":"CM Brummett","year":"2016","unstructured":"Brummett, C. M. et al. Preliminary validation of the Michigan Body Map. Pain 157, 1205\u20131212 (2016).","journal-title":"Pain"},{"key":"1290_CR168","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja, S. N. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161, 1976\u20131982 (2020).","journal-title":"Pain"},{"key":"1290_CR169","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/pmt-2020-0081","volume":"11","author":"MA Lumley","year":"2021","unstructured":"Lumley, M. A. et al. Emotional awareness and other emotional processes: implications for the assessment and treatment of chronic pain. Pain. Manag. 11, 325\u2013332 (2021).","journal-title":"Pain. Manag."},{"key":"1290_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2025.102000","volume":"62","author":"K Boersma","year":"2025","unstructured":"Boersma, K. & Flink, I. K. Key aspects concerning the role of emotion in the chronic pain experience. Curr. Opin. Psychol. 62, 102000 (2025).","journal-title":"Curr. Opin. Psychol."},{"key":"1290_CR171","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jpain.2023.03.008","volume":"24","author":"T Falasinnu","year":"2023","unstructured":"Falasinnu, T. et al. The problem of pain in the United States: a population-based characterization of biopsychosocial correlates of high impact chronic pain using the national health interview survey. J. Pain. 24, 1094\u20131103 (2023).","journal-title":"J. Pain."},{"key":"1290_CR172","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/ejp.1651","volume":"24","author":"P Vergne-Salle","year":"2020","unstructured":"Vergne-Salle, P. et al. The burden of pain in rheumatoid arthritis: impact of disease activity and psychological factors. Eur. J. Pain. 24, 1979\u20131989 (2020).","journal-title":"Eur. J. Pain."},{"key":"1290_CR173","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/acr.25359","volume":"76","author":"S Garg","year":"2024","unstructured":"Garg, S. et al. Multiplicative impact of adverse social determinants of health on outcomes in lupus nephritis: a meta-analysis and systematic review. Arthritis care Res. 76, 1232\u20131245 (2024).","journal-title":"Arthritis care Res."},{"key":"1290_CR174","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/0961203319851559","volume":"28","author":"EM Williams","year":"2019","unstructured":"Williams, E. M. et al. Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the peer approaches to lupus self-management (PALS) pilot study. Lupus 28, 937\u2013944 (2019).","journal-title":"Lupus"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01290-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:03:58Z","timestamp":1758629038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01290-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":174,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01290-1","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"18 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}